Delivery Order SPE2DB22D3301-SPE2DB25FZ0JV
- Not listed
- The Defense Logistics Agency awarded a $24,529.17 delivery order to AmerisourceBergen Drug Corp for 75-unit vials of Menopur, a fertility medication used in assisted reproductive procedures. This is a firm fixed price, competitively awarded contract with an ultimate completion date of July 24, 2025, with performance to be completed in Conshohocken, Pennsylvania. The award carries no set-aside designation, reflecting open competition among qualified pharmaceutical vendors. This delivery order...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Menopur 75 Unit Vials, a fertility medication used in assisted reproductive procedures. This firm fixed price delivery order, valued at $184,393.57, is set to be completed by August 29, 2025, with performance taking place at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award was made competitively without a set-aside designation,...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $43,836.60 for 75-unit vials of Menopur, a fertility medication, from the Defense Logistics Agency's Medical Supply Chain on August 27, 2025. The contract utilizes a firm fixed-price delivery order structure with an ultimate completion date of August 28, 2025. This award was made through competitive procedures without any set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania facility, where...
- The Defense Logistics Agency awarded a $36,530.50 delivery order to AmerisourceBergen Drug Corp for Menopur 75 Unit vials, with a completion date of September 2, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and...
- The Defense Logistics Agency awarded a delivery order valued at $72,376.16 to AmerisourceBergen Drug Corp for the supply of Menopur 75 Unit vials. The contract, issued on September 2, 2025, with an ultimate completion date of September 3, 2025, represents a firm fixed-price delivery order with no set-aside designation, indicating competitive award based on open competition. Performance will take place at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a $58,448.80 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Menopur 75 Unit Vials. The contract was awarded on August 27, 2025, with an ultimate completion date of August 28, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a $8,036.71 delivery order to AmerisourceBergen Drug Corp for Menopur 75 Unit Vials, with an ultimate completion date of July 24, 2025. This contract employs firm fixed pricing and was competitively awarded with no set-aside designation. The place of performance is the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $19,980.83 to AmerisourceBergen Drug Corp for the supply of Menopur 75 Unit Vials. The contract is firm fixed price with no set-aside designation and carries an ultimate completion date of August 18, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents a competitive award under the company's existing contract vehicle with DLA....
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $26,743.32, is for the delivery of 4,562,704,677 units of Menopur 75 unit vials, a medical product used in the treatment of infertility. The contract has a period of performance running through November 6, 2023. This delivery order is issued under AmerisourceBergen's...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $27,058.49 firm fixed-price delivery order is for the supply of 4,564,571,395 units of the drug Menopur, a medication used in fertility treatments. The contract has an ultimate completion date of May 13, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB25FZ0JVDelivery Order
The Defense Logistics Agency awarded a $46,140.29 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 75-unit vials of Menopur, a fertility medication commonly used in assisted reproductive therapy. This non-competitive delivery order was issued on September 2, 2025, with an ultimate completion date of September 3, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical supply transaction under the company's existing federal contracting relationships with DLA. This delivery order is a child contract issued under AmerisourceBergen's Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen supplies a comprehensive range of medications and medical supplies to support military healthcare systems and other government agencies. The company's role as a prime vendor in the DLA's Pharmaceutical Prime Vendor program enables efficient procurement of specialized medications like Menopur to meet Defense Health Agency and other federal healthcare customer requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $46.1k | 9/2/25 |